Understand the source comparison
Thymalin Dosage for Immune Reconstitution: Protocol Comparison
Age-related immune senescence 10mg SC 10 days Every 6 months Broad T-cell reconstitution across CD4+ and CD8+ subsets Gold standard for elderly populations. 6-month spacing prevents thymic suppression while maintaining counts Post-chemotherapy recovery Single
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Age-related immune senescence
- 10mg SC
- 10 days
- Every 6 months
- Broad T-cell reconstitution across CD4+ and CD8+ subsets
- Gold standard for elderly populations. 6-month spacing prevents thymic suppression while maintaining counts
- Post-chemotherapy recovery
- Single cycle 14–21 days post-chemo
- Accelerated thymocyte maturation during bone marrow recovery window
- Timing is critical. Earlier or later reduces efficacy by 30–40%
- Autoimmune rebalancing
- 5mg SC
- Every 3 months
- Preferential Treg differentiation to restore immune tolerance
- Lower dose is intentional. Higher doses dilute Treg-specific effect
- Chronic viral infection support
- 7.5mg SC
- Every 4 months
- CD8+ cytotoxic T-cell expansion for viral clearance
- Mid-range dose balances CD4+ helper support with CD8+ effector response
- Research baseline protocol
- General immune maintenance in healthy subjects
- Conservative starting point. Allows observation of individual response before escalation